*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
The Financial Mail on Sunday's Midas column touted shares of Hercules Site Services to its readers, highlighting its fast growth and "robust" long-term outlook.
The Financial Mail on Sunday's Midas column told readers to 'buy' shares of Literacy Capital, arguing that they should gain ground, "despite the choppy economic climate".
The Financial Mail on Sunday's Midas column recommended readers 'buy' shares of Phoenix Group, highlighting how it appeared to be on a path to strong growth and higher dividends.
The Financial Mail on Sunday's Midas column recommended investors book some profits on Clarkson following the shares' nearly ten-fold rise under the stewardship of chief executive officer Andi Case.
Investors in Judges Scientific should hold on to a "decent" amount of their shares in the company, even if they may be tempted to take some profits now at 8,500. 0p, the Financial Mail on Sunday's Midas column said.
The Financial Mail on Sunday's Midas column recommended readers buy shares of Serabi Gold, telling them that production was recovering and that profits were set to soar.
The Sunday Times's Lucy Tobin told readers that shares of business recovery specialist, Begbies Traynor, are a 'buy' given the outlook for a rise in corporate insolvencies.
The Financial Mail on Sunday's Midas column recommended shares of Impact Healthcare, as 'a long-term buy', touting the company's long-term growth prospects, dividend yield of over 5. 0% and management's attention to detail which they surmised was paying off.
The Financial Mail on Sunday's Midas column recommended shares of five companies to readers, pointing out that history proved that the best time to buy shares was often when everyone else was running scared.
The Financial Mail on Sunday's Midas column told readers to 'buy' shares of Defence outfit Chemring, arguing that the tide was turning for the sector as a whole due to heightened geopolitical tensions.
The Sunday Times's Sabah Meddings told readers to 'buy' shares of Made. com, predicting that the online furniture retailer would profit from easing supply snags and still high demand from millennials Europeans too.
The Financial Mail on Sunday's Joanne Hart told readers of the Midas column that the investment case for shares of BP and Shell now "seems pretty clear" and argued that both were likely to continue "richly rewarding" their shareholders via dividend payouts over the next five years.
The Financial Mail on Sunday's Midas column recommended readers 'buy' shares in Mears Group, arguing that their price did not reflect "recent progress, prospects or the resilience through tough economic times".
